Castleview Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
GI
MAA
CGH
CNB
Castleview Partners's MDT Position: Q2 2026 in Review
Castleview Partners sold out of Medtronic (MDT) in Q2 2026, closing a stake of 4,089 shares — an estimated $354K sold.
Castleview Partners first reported a position in MDT in Q2 2021 and held it in 16 quarters. The position peaked at $354K in Q1 2026. 425 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Castleview Partners reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Castleview Partners sold 4,089 Medtronic shares in Q2 2026, an estimated $354K.
- Castleview Partners first reported a position in Medtronic in Q2 2021 and held it in 16 quarters.
- Castleview Partners's Medtronic position peaked at $354K in Q1 2026.
- 425 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.